AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2690-4861/185
1 Food and Drug Control Centre (LFDA), Tripoli, Libya.
2 Medical Supply Organization (MSO), Tripoli, Libya.
3 Department of Medicinal Chemistry, Faculty of Pharmacy, University of Tripoli, Libya.
4 Zoology Department, Faculty of Science, Tripoli University, Libya.
5 Chemical Engineering Department, Faculty of Engineering, Tripoli University, Libya.
6 Department of Biosciences, University of Salzburg, Salzburg, Austria.
*Corresponding Author: Abdul M Gbaj, Professor of Genetics and Biochemistry, Department of Medicinal Chemistry, Faculty of Pharmacy, University of Tripoli, Libya.
Citation: Nisreen H Meiqal, Massaud S Maamar, Mohammed A Gbaj, A Hermann, Abdul M Gbaj, et al. (2021). Immunogenicity and Safety of Sinopharm Covid-19 Vaccine in Young Mice. International Journal of Clinical Case Reports and Reviews. 10(3); DOI:10.31579/2690-4861/185
Copyright: © 2021 Abdul M Gbaj, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 15 October 2021 | Accepted: 10 January 2022 | Published: 17 January 2022
Keywords: sinopharm covid-19 vaccine; mice; coronavirus disease; immunogenic; safety
Background and Aim: Vaccines to prevent SARS-CoV-2 infection may be considered a promising way for reduction of the pandemic. Many different vaccines have become obtainable for use in many countries. The present study aims to evaluate the immune response and the safety of Sinopharm COVID-19 vaccine on 14 days old mice.
Materials and Methods:Our experimental study was performed on two weeks old mice, selected by random allocation. The mice were divided into three groups of 12. Group one received asingle dose of 0.5 ml Sinopharm COVID-19 vaccine, group two received two doses of 0.5 ml Sinopharm COVID-19 vaccine, and group three (control) received two doses of 0.5 ml of 0.9 % NaCl.
Results: Our study shows that Sinopharm COVID-19 vaccine is safe and induces good immunity in young mice.
Conclusions: The Sinopharm COVID-19 vaccine was safe and immunogenic in 14 days old mice. The two doses of Sinopharm COVID-19 vaccine elicit a safe antibody response in young mice. Further post-marketing toxicity studies are required to assess potential hazards for children to evaluate the histopathological characteristics.
The severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2), also called COVID-19, has quickly spread over the whole world and raised severe public health distresses. The scientific society is intensely requested investigating treatments that would potentially be effective in fighting COVID-19 [1, 2]. During July, 2021 WHO revealed that the COVID-19 pandemic caused more than four million deaths worldwide. Vaccination has been established to limit the further spread of SARS-CoV-2 virus. Children are also vulnerable to SARS-CoV-2 infection, although they display milder clinical symptoms of the disease [3]. This susceptibility raises the possibility of transmission between family members and risk to elderly members who are more prone to the disease [4].
There are four categories of vaccines in use: whole virus, protein subunits, viral vectors and nucleic acid (RNA and DNA). There are additional vaccine candidates currently in the pipeline for COVID-19. All vaccines are trying to attain immunity to the virus, and some may be capable to stop transmission. By finding a proper molecule on the virus they are initiating an immune response to the antigen. In the case of COVID-19 the antigen is usually a characteristic spike protein found on the surface of the virus which assist attacks of human cells [5-7]. In case of using the entire virus (such as Sinovac and Sinopharm) it produces an immune response with the help of antigen presenting cells (APCs) such as dendritic cells (DCs) [8]. In particular, DCs have essential functions in capturing molecules, fragmenting them into smaller peptides and presenting the antigenic peptides on their major histocompatibility complex (MHC) I and II to prime T cells for the start of cellular and humoral immunity against the virus [9].
The study aims to evaluate the immune response of Sinopharm COVID-19 vaccine and its safety in young mice aged two weeks.
Experimental animals
Young Swiss Albino male mice (10 ± 2 g) with 14 days old were used for experiments. In order to reduce the contact caused by environmental alterations and handling during behavioral studies, mice were acclimatized to the Laboratory Animal Holding Center and laboratory surroundings for three days and at least one hour before experimentation, respectively. Mice were kept under standard conditions with food (low protein diet) and water available ad libitum. The animals were housed six per cage in a light-controlled room (12 h light/dark cycle, light on 07:00 h) at 27°C and 65% relative humidity. All experiments were carried out between 09:30 and 15:00 h. Each test group consisted of 12 mice, and each mouse was used only once. All animal experiments were conducted according to guidelines set by the Institutional Animal Ethics Committee of the National Medical Research Centre (NMRC35/2009).
Clinical and necropsy observations
This study represents one constituent of the safety evaluation program for using Sinopharm COVID-19 vaccine for very young mice to assess efficacy and toxicity. The aim was to evaluate these parameters following the administration of the proposed human vaccine dose. The mice were divided into three groups of 12. Group one received a single dose of 0.5 ml Sinopharm COVID-19 vaccine, Group two received two doses of 0.5 ml Sinopharm COVID-19 vaccine and the second dose was given after 21 days, and group three(control) received two doses of 0.5 ml of 0.9 % NaCl. Mice were examined every day for 40 days. Any signs of ill health were recorded daily. Blood samples for IgM and IgG were taken from animals on day 14 and day 30 after first vaccine application. At necropsy a full macroscopic examination was performed on each animal. Organs macroscopically examined were the spleen, lungs, liver, kidney, heart, brain, testes, and ovaries.
Statistical analysis
The difference among various treated groups and the control groups were analyzed using one-way-ANOVA followed by using unpaired Student’s t-test. The results were expressed as the mean ± SEM of the number of experiments, with p< 0 xss=removed>
Mice have been the most generally used animals in scientific research [10, 11]. This is could be attributed to the fact that the mouse genome is 99% identical to the human genome, and mice have similar patterns with respect to human organs and systemic physiology.
The Sinopharm Beijing Covid-19 vaccine is produced by Beijing Institute of Biological Products (BIBP), subsidiary of China National Biotec Group (CNBG), they uses inactive or weakened virus (19nCoV-CDC-Tan-HB02) strain as antigen which based on a form of the virus that has been inactivated or weakened so that it does not cause disease, but is still able to produce an immune response. It has been reported that the effectiveness of the vaccine is approximately 87.5% for the prevention of hospitalizations of Covid-19 patients, 65.9% for prevention of Covid-19, 90.3% for the prevention of intensive care unit admissions, and 86.3% for the prevention of Covid-19-related deaths [12]. Furthermore, children younger than 12 years old are at their crucial phase of growth and development; concern must be taken to assess the long-term effect of COVID-19 vaccine on their growth and development. In addition, children whom are going to be vaccinated should have enough immunity and safety against COVID-19 vaccine [13].
It has been reported that Pfizer and Moderna messenger RNA (mRNA) vaccines studied in children older than 12 years and were found safe and effective. In addition, Pfizer and Moderna vaccines were also tested in children under 12, with the aim of involving babies from just six months old. Although teenagers only seldom get badly sick with Covid-19, they are able to spread the infection. Hence, vaccination will be able to assist stopping the pandemic [14]. Sinopharm's institute in Wuhan approved for emergency utilization on children aged between three and seventeen by the China National Biotec Group on August, 2021. China began to permit people aged between three and seventeen to obtain a dose of COVID-19 vaccines in early June 2021, making it the first country to declare the endorsement of vaccines for such a young age group [15]. None of the mice used in the study showed any sign of abnormality or ill health throughout the 42 days post-immunization observation for the three groups after the first dose of immunization. At necropsies no macroscopic treatment related changes were observed. Antibody binding the SARS-CoV-2 spike protein was induced by vaccination, and, as expected, the temporal induction of anti-spike IgM was faster than that of IgG. The mice injected with Sinopharm COVID-19 vaccine or 0.9% sodium chloride solutions were generally in good condition, no obvious clinical unusual symptoms were observed, and no death occurred during the observation period. The mice body weights in control and vaccine groups increased but the increase was more with the vaccinated group by around 1.5 times compared with the initial weights. There were significant differences in body weights and food intakes noted between the vaccine and negative control groups throughout the study period. Furthermore, no abnormal changes were found in the gross autopsy results of all mice investigated.
Our study shows that the Sinopharm COVID-19 vaccine given to 14 days old mice produces an immune response with no side effects ascertain its safety and protection efficacy against COVID-19. We highly recommend post-marketing surveillance of the vaccine safety when given for children for a longer period than that in adults.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
